Dr. Julia Nemiroff, MD

Dr. Nemiroff practices at Retina And Eye Clinic in Palm Beach Gardens, Florida.

Dr. Nemiroff's NPI, 1497018006, was assigned on June 19, 2012. Dr. Nemiroff graduated from New York University School of Medicine in 2012. Dr. Nemiroff holds Florida license ME131906.

Dr. Nemiroff's primary practice is Retina and Eye Clinic, at 2560 Rca Blvd Suite 112 Suite 112, Palm Beach Gardens, FL 33410-3337. The practice phone is (561) 331-1797.

Dr. Nemiroff's primary practice is Retina And Eye Clinic in Palm Beach Gardens, Florida. Dmand AI also links Dr. Nemiroff to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nemiroff practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Nemiroff's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Nemiroff is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Nemiroff's licenses on file in 2 states: Florida and California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Nemiroff treats.

CMS data shows 8,720 Medicare services from Dr. Nemiroff across 25 procedure codes in 2024, for 573 Medicare patients. Medicare paid $480,042 for them.

CMS counts 573 Medicare patients who saw Dr. Nemiroff in 2024. The largest group is 65 to 74, with 304 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nemiroff's median patient age at 70, with 59% women.

In 2024, Dr. Nemiroff wrote 1,471 Medicare Part D claims for 372 patients. 58% of them were for generic drugs. CMS names the drug for 1,390 of them, across 16 drugs with 11 or more claims each, at $53,032 in total drug cost. In 2023, CMS named 1,303 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nemiroff for performance year 2024, reported individually. Dr. Nemiroff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 127 procedures of cataract surgery by Dr. Nemiroff, more than 78% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Nemiroff, published from 2011 to 2016. The most frequent topics are Tomography, Optical Coherence and Visual Acuity. Dr. Nemiroff's most frequent co-authors are David Sarraf, MD, Samuel Baharestani, MD and Kiran Bhagwan Amesur, MD.

Dmand AI links Dr. Nemiroff to 2 clinical trials. Conditions studied include Glaucoma, Open-Angle, Macular Degeneration and Glaucoma. Allergan sponsors the most, 2.

CMS Open Payments shows 93 general payments to Dr. Nemiroff from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $657.

Dr. Nemiroff graduated from New York University School of Medicine in 2012.

Dr. Nemiroff is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.